Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Markovic

Showing results (271-280 of 368) with videos related to

Pageof 37
Sort By:
Leukemia & Lymphoma|July 7, 2007
Effectiveness of second line salvage chemotherapy with ifosfamide, carboplatin, and etoposide in patients with relapsed diffuse large B-cell lymphoma not responding to cis-platinum, cytosine arabinoside, and dexamethasoneLijo Simpson, Stephen M Ansell, Joseph P Colgan, et al.
JAMA Network Open|August 9, 2020
Association of Sex, Age, and Eastern Cooperative Oncology Group Performance Status With Survival Benefit of Cancer Immunotherapy in Randomized Clinical Trials: A Systematic Review and Meta-analysisFang Yang, Svetomir N Markovic, Julian R Molina, et al.
American Journal of Clinical Oncology|June 1, 2002
Phase II trial of KW2189 in patients with advanced malignant melanomaSvetomir N Markovic, Vera J Suman, Allen M Vukov, et al.
Journal of Surgical Oncology|July 9, 2022
Merkel cell carcinoma of unknown primary: Clinical presentation and outcomesSamuel E Broida, Xiao T Chen, Christian L Baum, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 5, 2026
Urinary CXCL-9 Outperforms TNF-α for Non-invasive Diagnosis of Immune Checkpoint Inhibitor-Associated Acute Interstitial NephritisCoraima Claudia Nava Chavez, Sheila Bermejo, Victor Cuenca Narvaez, et al.
Immunotherapy|September 15, 2011
The dynamic human immune response to cancer: it might just be rocket scienceShernan G Holtan, Roxana S Dronca, Wendy K Nevala, et al.
Cancer Immunology, Immunotherapy : CII|August 7, 2015
Gene expression patterns in CD4+ peripheral blood cells in healthy subjects and stage IV melanoma patientsSara J Felts, Virginia P Van Keulen, Adam D Scheid, et al.
Immunotherapy|August 6, 2020
Peptide vaccine with glucopyranosyl lipid A-stable oil-in-water emulsion for patients with resected melanomaEric P Grewal, Courtney L Erskine, Wendy K Nevala, et al.
Frontiers in Immunology|December 22, 2022
Quantitative spatial evaluation of tumor-immune interactions in the immunotherapy setting of metastatic melanoma lymph nodesRachel L G Maus, Alexey A Leontovich, Raymond M Moore, et al.
Melanoma Research|May 15, 2020
Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patientsJesus Vera Aguilera, Jonas Paludo, Robert R McWilliams, et al.
Pageof 37

Showing results (271-280 of 368) with videos related to

Sort By:
Pageof 37
Leukemia & Lymphoma|July 7, 2007
Effectiveness of second line salvage chemotherapy with ifosfamide, carboplatin, and etoposide in patients with relapsed diffuse large B-cell lymphoma not responding to cis-platinum, cytosine arabinoside, and dexamethasoneLijo Simpson, Stephen M Ansell, Joseph P Colgan, et al.
JAMA Network Open|August 9, 2020
Association of Sex, Age, and Eastern Cooperative Oncology Group Performance Status With Survival Benefit of Cancer Immunotherapy in Randomized Clinical Trials: A Systematic Review and Meta-analysisFang Yang, Svetomir N Markovic, Julian R Molina, et al.
American Journal of Clinical Oncology|June 1, 2002
Phase II trial of KW2189 in patients with advanced malignant melanomaSvetomir N Markovic, Vera J Suman, Allen M Vukov, et al.
Journal of Surgical Oncology|July 9, 2022
Merkel cell carcinoma of unknown primary: Clinical presentation and outcomesSamuel E Broida, Xiao T Chen, Christian L Baum, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 5, 2026
Urinary CXCL-9 Outperforms TNF-α for Non-invasive Diagnosis of Immune Checkpoint Inhibitor-Associated Acute Interstitial NephritisCoraima Claudia Nava Chavez, Sheila Bermejo, Victor Cuenca Narvaez, et al.
Immunotherapy|September 15, 2011
The dynamic human immune response to cancer: it might just be rocket scienceShernan G Holtan, Roxana S Dronca, Wendy K Nevala, et al.
Cancer Immunology, Immunotherapy : CII|August 7, 2015
Gene expression patterns in CD4+ peripheral blood cells in healthy subjects and stage IV melanoma patientsSara J Felts, Virginia P Van Keulen, Adam D Scheid, et al.
Immunotherapy|August 6, 2020
Peptide vaccine with glucopyranosyl lipid A-stable oil-in-water emulsion for patients with resected melanomaEric P Grewal, Courtney L Erskine, Wendy K Nevala, et al.
Frontiers in Immunology|December 22, 2022
Quantitative spatial evaluation of tumor-immune interactions in the immunotherapy setting of metastatic melanoma lymph nodesRachel L G Maus, Alexey A Leontovich, Raymond M Moore, et al.
Melanoma Research|May 15, 2020
Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patientsJesus Vera Aguilera, Jonas Paludo, Robert R McWilliams, et al.
Pageof 37